Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves' ophthalmopathy patients

European Journal of Endocrinology

Volumn 155, Issue 5, 2006, Pages 681-685

  Konuk, E Berrin Yuksel ^a   Konuk, Onuk ^a,b   Misirlioglu, Muge ^a   Menevse, Adnan ^a   Unal, Mehmet ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLOOXYGENASE 2; MESSENGER RNA;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; EYE INFLAMMATION; FEMALE; HUMAN; MALE; NEUROPATHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ACTINS; ADIPOSE TISSUE; ADULT; CYCLOOXYGENASE 2; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; ORBIT; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33845263695     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02280     Document Type: Article

References (15)

1. Prabhakar BS, Bahn RS & Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocrine Reviews 2003 24 802-835.
2. Ajjan RA & Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. Journal of Endocrinological Investigation 2004 27 237-245.
3. Smith TJ. Novel aspects of orbital fibroblast pathology. Journal of Endocrinological Investigation 2004 27 246-253.
4. Smith WL, DeWitt DL & Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annual Review of Biochemistry 2000 69 145-182.
5. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB & Lipsky PE. Cyclooxygenase in biology and disease. FASEB Journal 1998 12 1063-1073.
6. Han R, Tsui S & Smith TJ. Up-regulation of prostaglandine E2 synthesis by interleukin 10-in human orbital fibroblasts involves coordinate induction of prostaglandine-endoperoxide H synthase-2 and glutathione dependent prostaglandine E2 synthase expression. Journal of Biological Chemistry 2002 277 16355-16364.
7. Wang HS, Cao HJ, Winn VD, Rezanka LJ, Frobert Y, Evans CH, Sciaky D, Young DA & Smith TJ. Leukoregulin induction of prostaglandine-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation. Journal of Biological Chemistry 1996 271 22718-22728.
8. Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps RP & Smith TJ. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluranan synthesis and prostaglandine-endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy, Journal of Biological Chemistry 1998 273 29615-29625.
9. Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE & Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' orbitopathy experience. European Journal of Endocrinology 2003 148 491-495.
10. Mourits MP, Prummel MF, Wiersinga WM & Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology 1997 47 9-14.
11. Prummel MF, Mourits MF, Berghout A, Krenning EP. van der Gaag R, Koornneef L & Wiersinga WM. Prednisone and cylcosporine in the treatment of severe Graves' ophthalmopathy. New England Journal of Medicine 1989 321 1353-1359.
12. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001 29 2002-2007.
13. Kumar S & Bahn RS. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 2003 88 4246-4250.
14. Rundle FF. Eye signs of Graves' disease. In The Thyroid, pp 171-197. EdsR Pitt-Rivers & WR Trotter, Washington, DC: Butterworths and Co, 1964.
15. Kazim M, Trokel S & Moore S. Treatment of acute Graves' orbitopathy. Ophthalmology 1991 98 1443-1448.